FB Pixel no scriptNews | KrASIA
MENU
KrASIA

News

News

Hengrui weighs Hong Kong IPO to drive the next phase of global expansion

A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.

4 mins read
  • The merger drives BYD’s endgame: a self-developed intelligent driving system ready for the market.

    News

    BYD unifies autonomous driving teams to compete in high-end market

    4 mins read

Most Recent

See All